Fresenius Medical Care Exceeds Market Expectations in Q2 2026

Fresenius Medical Care AG has announced its financial results for the second quarter of 2026, surpassing market expectations. The operating income, excluding special items, reached EUR 569 million, marking a 23% increase at constant currency from the previous year. This figure exceeds the market consensus of EUR 515 million, driven primarily by robust growth in the Care Delivery segment.

Group revenue also saw an uptick, climbing by 4% at constant currency to EUR 4,861 million, slightly higher than the anticipated EUR 4,792 million. The company has maintained its financial outlook for the full year 2026, citing constant currency and the exclusion of special items as factors in these figures.

The adherence to current laws and policies forms the basis for the financial projections. The detailed reconciliation tables will be available on the company’s website following this announcement.